Enanta Pharmaceuticals (ENTA) Change in Account Payables (2012 - 2026)
Enanta Pharmaceuticals posted quarterly Change in Account Payables of $2.5 million for Q1 2026, up 183.85% year-on-year from $873000.0 in Q1 2025, and up 4033.33% on a QoQ basis from -$63000.0 in Q4 2025.
Enanta Pharmaceuticals (ENTA) has 15 years of Change in Account Payables data on file, last reported at $2.5 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 183.85% year-over-year to $2.5 million; the trailing twelve-month figure through Mar 2026 stood at $399000.0 (up 1230.0% YoY), and the FY2025 full-year result was -$1.3 million, down 216.67% from the prior year.
- Change in Account Payables for Q1 2026 stood at $2.5 million, up from -$63000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $6.6 million in Q1 2023 and bottomed at -$5.1 million in Q2 2022.
- The 5-year median for Change in Account Payables is -$686000.0 (2022), against an average of -$201882.4.
- The widest annual swing landed in 2022, when Change in Account Payables sank 2923.33%; it then jumped 854.23% in 2023.
- A 5-year view of Change in Account Payables shows it stood at -$686000.0 in 2022, then surged by 854.23% to $5.2 million in 2023, then plunged by 103.25% to -$168000.0 in 2024, then surged by 62.5% to -$63000.0 in 2025, then surged by 4033.33% to $2.5 million in 2026.
- The last three Change in Account Payables figures came in at $2.5 million (Q1 2026), -$63000.0 (Q4 2025), and -$723000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | 2.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.48 Mn |
| Mar 31, 2026 | 2.48 Mn |
| Dec 31, 2025 | -63,000.00 |
| Dec 31, 2025 | -63,000.00 |
| Sep 30, 2025 | -723,000.00 |
| Sep 30, 2025 | -723,000.00 |
| Jun 30, 2025 | -1.29 Mn |
| Jun 30, 2025 | -1.29 Mn |
| Mar 31, 2025 | 873,000.00 |
| Mar 31, 2025 | 873,000.00 |
| Dec 31, 2024 | -168,000.00 |
| Dec 31, 2024 | -168,000.00 |
| Sep 30, 2024 | -1.54 Mn |
| Sep 30, 2024 | -1.54 Mn |
| Jun 30, 2024 | 863,000.00 |
| Jun 30, 2024 | 863,000.00 |
| Mar 31, 2024 | -4.91 Mn |
| Mar 31, 2024 | -4.91 Mn |
| Dec 31, 2023 | 5.17 Mn |
| Dec 31, 2023 | 5.17 Mn |
| Sep 30, 2023 | -3.83 Mn |
| Sep 30, 2023 | -3.83 Mn |
| Jun 30, 2023 | -3.28 Mn |
| Jun 30, 2023 | -3.28 Mn |
| Mar 31, 2023 | 6.65 Mn |
| Mar 31, 2023 | 6.65 Mn |
| Dec 31, 2022 | -686,000.00 |
| Dec 31, 2022 | -686,000.00 |
| Sep 30, 2022 | 3.92 Mn |
| Sep 30, 2022 | 3.92 Mn |
| Jun 30, 2022 | -5.08 Mn |
| Jun 30, 2022 | -5.08 Mn |
| Mar 31, 2022 | -1.81 Mn |
| Mar 31, 2022 | -1.81 Mn |
| Dec 31, 2021 | -1.66 Mn |
| Dec 31, 2021 | -1.66 Mn |
| Sep 30, 2021 | 3.58 Mn |
| Sep 30, 2021 | 3.58 Mn |
| Jun 30, 2021 | 180,000.00 |
| Jun 30, 2021 | 180,000.00 |
| Mar 31, 2021 | -560,000.00 |
| Mar 31, 2021 | -560,000.00 |
| Dec 31, 2020 | 575,000.00 |
| Dec 31, 2020 | 575,000.00 |
| Sep 30, 2020 | -211,000.00 |
| Sep 30, 2020 | -211,000.00 |
| Jun 30, 2020 | 59,000.00 |
| Jun 30, 2020 | 59,000.00 |
| Mar 31, 2020 | -552,000.00 |
| Mar 31, 2020 | -552,000.00 |
| Dec 31, 2019 | -179,000.00 |
| Dec 31, 2019 | -179,000.00 |
| Sep 30, 2019 | 152,000.00 |
| Sep 30, 2019 | 152,000.00 |
| Jun 30, 2019 | -1.25 Mn |
| Jun 30, 2019 | -1.25 Mn |
| Mar 31, 2019 | 2.76 Mn |
| Mar 31, 2019 | 2.76 Mn |
| Dec 31, 2018 | 124,000.00 |
| Dec 31, 2018 | 124,000.00 |
| Sep 30, 2018 | -129,000.00 |
| Sep 30, 2018 | -129,000.00 |
| Jun 30, 2018 | 881,000.00 |
| Jun 30, 2018 | 881,000.00 |
| Mar 31, 2018 | 694,000.00 |
| Mar 31, 2018 | 694,000.00 |
| Dec 31, 2017 | -129,000.00 |
| Dec 31, 2017 | -129,000.00 |
| Sep 30, 2017 | -2.08 Mn |
| Sep 30, 2017 | -2.08 Mn |
| Jun 30, 2017 | 2.03 Mn |
| Jun 30, 2017 | 2.03 Mn |
| Mar 31, 2017 | 1.98 Mn |
| Mar 31, 2017 | 1.98 Mn |
| Dec 31, 2016 | -1.29 Mn |
| Dec 31, 2016 | -1.29 Mn |
| Sep 30, 2016 | 774,000.00 |
| Sep 30, 2016 | 774,000.00 |
| Jun 30, 2016 | -483,000.00 |
| Jun 30, 2016 | -483,000.00 |
| Mar 31, 2016 | 1.01 Mn |
| Mar 31, 2016 | 1.01 Mn |
| Dec 31, 2015 | 149,000.00 |
| Dec 31, 2015 | 149,000.00 |
| Sep 30, 2015 | -211,000.00 |
| Sep 30, 2015 | -211,000.00 |
| Jun 30, 2015 | -820,000.00 |
| Jun 30, 2015 | -820,000.00 |
| Mar 31, 2015 | 1.78 Mn |
| Mar 31, 2015 | 1.78 Mn |
| Dec 31, 2014 | -1.30 Mn |
| Dec 31, 2014 | -1.30 Mn |
| Sep 30, 2014 | 589,000.00 |
| Sep 30, 2014 | 589,000.00 |
| Jun 30, 2014 | -506,000.00 |
| Jun 30, 2014 | -506,000.00 |
| Mar 31, 2014 | 964,000.00 |
| Mar 31, 2014 | 964,000.00 |
| Dec 31, 2013 | -648,000.00 |
| Dec 31, 2013 | -648,000.00 |
| Sep 30, 2013 | 735,000.00 |
| Sep 30, 2013 | 735,000.00 |
| Jun 30, 2013 | -151,000.00 |
| Jun 30, 2013 | -151,000.00 |
| Mar 31, 2013 | -911,000.00 |
| Mar 31, 2013 | -911,000.00 |
| Dec 31, 2012 | 442,000.00 |
| Dec 31, 2012 | 442,000.00 |
| Sep 30, 2012 | 828,000.00 |
| Sep 30, 2012 | 828,000.00 |
| Jun 30, 2012 | 52,000.00 |
| Jun 30, 2012 | 52,000.00 |